BICARA THERAPEUTICS INC. - COMMON STOCK

12,13

07-февраля-25 16:45:00

15 мин. задержка

Акции

-0,47

-3,73%

Сегодняшний диапазон

11,85 - 12,99

ISIN

N/A

Источник

NASDAQ

Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium

27 янв 2025 08:00:15 Источник Nasdaq GlobeNewswire
Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

12 ноя 2024 07:30:49 Источник Nasdaq GlobeNewswire
Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference

11 ноя 2024 16:01:02 Источник Nasdaq GlobeNewswire
Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

16 сен 2024 16:01:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.